Kidney Cancer

>

Latest News

Exciting New Treatment Updates Are on the Horizon for Advanced RCC
Exciting New Treatment Updates Are on the Horizon for Advanced RCC

May 18th 2024

Moshe Ornstein, MD, highlights recent treatment updates for renal cell carcinoma.

Pembrolizumab also demonstrated a disease-free survival benefit vs placebo for patients with clear-cell renal cell carcinoma.
Pembrolizumab Prolongs Survival in Clear-Cell RCC

April 18th 2024

Toripalimab plus axitinib is now an approved regimen in China for patients with medium- to high-risk unresectable or metastatic renal cell carcinoma.
Toripalimab Combo Receives Chinese Approval for Advanced RCC

April 10th 2024

Findings from a phase 2 trial highlight an acceptable adverse effect profile and renal function with stereotactic ablative body radiotherapy in primary renal cell cancer.
Stereotactic Radiation Appears Effective in Primary Renal Cell Cancer

March 20th 2024

Practices should not differentiate treatment options based on race for patients with metastatic renal cell carcinoma, according to Jasmeet Kaur, MD.
Comparable Findings in White and Black Populations for ICI Use in Metastatic RCC

February 20th 2024

More News